Operating Income

Operating Income

Roivant Sciences Operating Income decreased by 10.7% to -$339.15M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 23.6%, from -$274.38M to -$339.15M. Over 3 years (FY 2021 to FY 2024), Operating Income shows an upward trend with a -9.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.

Detailed definition

Operating income is the profit realized from a company's core business operations after deducting all operating expenses...

Peer comparison

A standard benchmark for operational performance; peers are compared based on operating margin percentages.

Metric ID: operating_income

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value-$154.39M-$684.43M-$246.02M-$266.80M-$282.31M-$280.77M-$378.08M$0.00-$276.41M-$213.89M$5.13B$0.00-$102.24M-$341.71M-$274.38M-$284.97M-$284.92M-$306.23M-$339.15M
QoQ Change-343.3%+64.1%-8.4%-5.8%+0.5%-34.7%+100.0%+22.6%>999%-100.0%-234.2%+19.7%-3.9%+0.0%-7.5%-10.7%
YoY Change-82.9%+59.0%-53.7%+100.0%+2.1%+23.8%>999%+63.0%-59.8%-105.4%-178.7%+10.4%-23.6%
Range-$684.43M$5.13B
CAGR+19.1%
Avg YoY Growth+93.1%
Median YoY Growth+2.1%
Current Streak2 quarters decline

Frequently Asked Questions

What is Roivant Sciences's operating income?
Roivant Sciences (ROIV) reported operating income of -$339.15M in Q4 2025.
How has Roivant Sciences's operating income changed year-over-year?
Roivant Sciences's operating income decreased by 23.6% year-over-year, from -$274.38M to -$339.15M.
What is the long-term trend for Roivant Sciences's operating income?
Over 3 years (2021 to 2024), Roivant Sciences's operating income has grown at a -9.5% compound annual growth rate (CAGR), from -$1.35B to -$1.00B.
What does operating income mean?
The profit a company makes from its core business operations before interest and taxes.